Qube Research & Technologies (QRT)’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-106,544
Closed -$2.46M 2627
2020
Q4
$2.46M Buy
+106,544
New +$2.46M 0.03% 534